Pain Medicines for Period Pain in Crohn's Disease

(AVID-CD Trial)

Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this pilot study is to prepare for a larger study that will compare the effectiveness and safety of two common pain medications, ibuprofen and acetaminophen, to help treat period cramps in women with Crohn's disease. The goal of this study is to identify any challenges in running a larger study. The investigators will track how many people sign up for the study, how well participants follow the study plan, how many people stay in the study, and whether they are able to complete all the study activities, such as taking the medication, submitting samples, and filling out surveys.

During the study, participants will undergo a screening visit that includes a blood draw, physical exam, pregnancy test, stool testing, and complete surveys about Crohn's disease and menstrual cycles. Once this visit is complete, the rest of the study will occur at home.

Participants will be assigned to take either ibuprofen or acetaminophen to help treat period cramps for four menstrual cycles in a row. Participants will take ibuprofen for two cycles and acetaminophen for two cycles. Participants will know which medication is being taken at any given time, but the order in which they take the medications will be randomly assigned.

Before each menstrual cycle, participants will submit a stool sample and fill out a short (\<1 minute) electronic survey. When participants develop period cramps, they will take the assigned medication for three days and fill out short (\<1 minute) electronic surveys about their cramps. After participants finish taking the medication for three days, they will submit another stool sample and fill out two more short (\<1 minute) electronic surveys. After have completing this process for four menstrual cycles, a remote interview with a researcher to give feedback on the study will be conducted.

Who Is on the Research Team?

EJ

Erica J Brenner, MD, MSCR

Principal Investigator

University of North Carolina, Chapel Hill

Are You a Good Fit for This Trial?

This trial is for women aged 18-44 with Crohn's Disease in stable remission, experiencing period pain and having regular menstrual cycles. Participants must not be using corticosteroids, should use contraception or practice abstinence.

Inclusion Criteria

I am between 18 and 44 years old.
I was assigned female at birth.
I have been diagnosed with Crohn's Disease.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (in-person)

Treatment

Participants take either ibuprofen or acetaminophen for four menstrual cycles, with medication taken for three days during each cycle.

4 months
Remote participation with electronic surveys and stool sample submissions

Follow-up

Participants are monitored for safety and effectiveness after treatment, including a remote interview to provide feedback on the study.

1 month
1 remote interview

What Are the Treatments Tested in This Trial?

Interventions

  • Acetaminophen
  • Ibuprofen

Trial Overview

The AVID-CD study tests the effectiveness of ibuprofen versus acetaminophen on period cramps in women with Crohn's disease. It involves taking each medication for two menstrual cycles and tracking symptoms through surveys and stool samples.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Group I: Ibuprofen, Acetaminophen, Ibuprofen, AcetaminophenExperimental Treatment2 Interventions
Group II: Ibuprofen, Acetaminophen, Acetaminophen, IbuprofenExperimental Treatment2 Interventions
Group III: Acetaminophen, Ibuprofen, Ibuprofen, AcetaminophenExperimental Treatment2 Interventions
Group IV: Acetaminophen, Ibuprofen, Acetaminophen, IbuprofenExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

American College of Gastroenterology

Collaborator

Trials
40
Recruited
6,900+